A Study to Evaluate the Effect of AZD8154 Administered via Nebulizer Once Daily in Subjects with Mild Allergic Asthma Challenged with an Inhaled Allergen

Trial Identifier: D8900C00004
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT04187508
Start Date: February 2020
Primary Completion Date: November 2021
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Canada, AB Calgary, AB, Canada, T2N 4Z6
Canada, AB Edmonton, AB, Canada, T6G 2G3
Canada, BC Vancouver, BC, Canada, V5Z 1M9
Canada, ON Hamilton, ON, Canada, L8N 3Z5
Canada, SK Saskatoon, SK, Canada, S7N 0W8